fbpx
QQQ
-1.91
368.39
-0.52%
DIA
-1.32
352.14
-0.38%
SPY
-2.11
442.76
-0.48%
TLT
+ 0.70
148.12
+ 0.47%
GLD
-1.36
172.53
-0.79%

10 Biggest Price Target Changes For Friday

October 12, 2018 9:58 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
  • Barclays boosted the price target for UnitedHealth Group Inc (NYSE:UNH) from $265 to $280. UnitedHealth shares closed at $257.12 on Thursday.
  • Mizuho lowered the price target on Alder Biopharmaceuticals Inc (NASDAQ:ALDR) from $29 to $15. Alder Biopharmaceuticals shares closed at $13.40 on Thursday.
  • Baird cut Blackbaud, Inc. (NASDAQ:BLKB) price target from $105 to $82. Blackbaud shares closed at $72.80 on Thursday.
  • Canaccord Genuity lifted the price target for Square Inc (NYSE:SQ) from $60 to $90. Square shares closed at $69.03 on Thursday.
  • Buckingham cut the price target for Old Dominion Freight Line (NASDAQ:ODFL) from $162 to $154. Old Dominion Freight shares closed at $136.31 on Thursday.
  • Morgan Stanley raised Marathon Petroleum Corp (NYSE:MPC) price target from $100 to $110. Marathon Petroleum shares closed at $78.73 on Thursday.
  • KeyBanc lowered the price target for PPG Industries, Inc. (NYSE:PPG) from $128 to $119. PPG shares closed at $96.38 on Thursday.
  • Stifel Nicolaus lowered the price target on Netflix, Inc. (NASDAQ:NFLX) from $406 to $395. Netflix shares closed at $321.10 on Thursday.
  • UBS cut the price target for Alibaba Group Holding Ltd (NYSE:BABA) from $230 to $220. Alibaba shares closed at $141.90 on Thursday.
  • Citigroup raised HCA Healthcare Inc (NYSE:HCA) price target from $136 to $156. HCA shares closed at $132.43 on Thursday.

 

 

 

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

10 Biggest Price Target Changes For Tuesday

Canaccord Genuity Downgrades Alder BioPharmaceuticals to Hold, Announces $20 Price Target

Mizuho Reiterates Neutral on Alder BioPharmaceuticals, Raises Price Target to $18

Credit Suisse Reiterates Neutral on Alder BioPharmaceuticals, Raises Price Target to $19